You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CORT Sale Disclosure
Mokari Atabak · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$164.9
Mokari Atabak Chief Financial Officer
CORT
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
CORT daily price context
Close on/before transaction
$83.12
Jun 15, 2026
First close after public filing
$79.91
Jun 18, 2026
30-day return after filing
+13.28%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2 shares @ $82.45
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-274224
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$4.02M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Corcept Therapeutics Inc CORT | Exercise | Jun 15, 2026 | $770.4K |
| Corcept Therapeutics Inc CORT | Sale | Jun 15, 2026 | $754.92K |
| Corcept Therapeutics Inc CORT | Sale | Jun 15, 2026 | $896.92K |
| Corcept Therapeutics Inc CORT | Sale | Jun 15, 2026 | $1.59M |
| Corcept Therapeutics Inc CORT Current | Sale | Jun 15, 2026 | $164.9 |
| Corcept Therapeutics Inc CORT | Exercise | Jun 15, 2026 | $0 |